As a regulator of target genes associated with EMT, strategies targeting TCF7L1, its down-regulated targets, or its corepressors may offer a potential therapeutic strategy to reduce metastasis in CRC patients. This evidence concerns the gene TCF7L1 and colorectal carcinoma.